IONIS-AGT-LRx / Ionis 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IONIS-AGT-LRx / Ionis
ASTRAAS, NCT04714320: A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure

Completed
2
160
Canada, US
IONIS-AGT-LRx, ISIS 757456, Placebo
Ionis Pharmaceuticals, Inc.
Hypertension
09/22
09/22
ASTRAAS-HF, NCT04836182 / 2020-005878-10: A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Participants With Chronic Heart Failure With Reduced Ejection Fraction

Completed
2
72
Europe, US
IONIS-AGT-LRx, ISIS 757456, Placebo
Ionis Pharmaceuticals, Inc.
Chronic Heart Failure With Reduced Ejection Fraction
10/22
01/23

Download Options